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Abstract 
Cefadroxil drug loaded biopolymeric films of chitosan-furfural schiff base were 
prepared by reacting chitosan with furfural in presence of acetic acid and 
perchloric acid respectively for the external use. Prepared films were evaluated 
for their strength, swelling index, thickness, drug content, uniformity, tensile 
strength, percent elongation, FTIR spectral analysis and SEM. The results of 
in vitro diffusion studies revealed that the films exhibited enhanced drug 
diffusion as compared to the films prepared using untreated chitosan. The films 
also demonstrated good to moderate antibacterial activities against selective 
gram positive and gram negative bacteria.  
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Introduction  
Chitosan is a modified naturally occurring carbohydrate polymer derived from chitins which 
are found in crustaceans, fungi, insects and some algae [1–4]. Chitosan can be used in 
the diverse fields ranging from flocculent for seed coating, toiletry components, controlled 
drug delivery systems [5], membrane based transdermal drug delivery systems [6–14], 
wound-healing, dressing material and artificial skins etc. Chitosan having high molecular 910  R. B. Dixit et al.:    
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weight has been reported to have good film-forming properties [15] due to its intra- and 
intermolecular hydrogen bonding [6,  16–18]. The characteristics of chitosan film varied 
from one report to another might be due to difference in the source of chitin used to 
prepare chitosan, as well as type of solvents, methods of film preparation, and type and 
amount of plasticizers used, also affect the quality of the chitosan films [16]. There are 
reports about schiff base of chitosan and its film forming ability because of its potentiality in 
the field of prolonged drug delivery system and in some other type of novel drug delivery 
systems [19–22]. Moreover, cefadroxil is a broad spectrum antibiotic that acts against an 
extensive variety of bacteria, including Gram-positive and Gram-negative bacteria. 
Cefadroxil belongs to a group of cephalosporin antibiotics, which are used to treat many 
different types of bacterial infections [23]. However, Schiff base prepared by reacting 
chitosan and furfural has not been reported so far. Therefore, the present work aimed to 
develop and evaluate the cefadroxil loaded biopolymeric films of chitosan-furfural Schiff 
base by the reaction of amino group of chitosan with aldehyde group of furfural.  
Materials and Methods 
Materials 
Chitosan with a molecular weight 4.5 x 10
5 g/mol, degree of deacetylation 78% and 
viscosity 225 cp was obtained as a gift sample from Fish Processing Division, Central 
Institute of Fisheries Technology, Cochin, Kerala, India, and was used after purification. 
Furfural was purchased from LOBA chemicals, India. Glacial acetic acid was purchased 
from National Chemicals, India. Cefadroxil obtained as a gratis sample from Southern 
Pharmaceutical Limited, Baroda, India. All other chemicals used were of analytical reagent 
grade. 
Methods 
Preparation of Cefadroxil Loaded Plain Chitosan Film (F1) 
Chitosan film was prepared by following the reported  method [24]. Accordingly, 1 g 
chitosan was dissolved in 12.8 mL acetic acid solution (1% v/v) by vigorous agitation for 30 
minutes. The solution containing vessel was immersed in boiling water bath for 10 
minutes, cooled down to room temperature and solution was filtered through glass-wool to 
remove undissolved particles of chitosan. The resultant solution was further stirred on 
magnetic stirrer at 200 rpm and at 37 °C for 8 hours. After that, 3.2 mL glycerol (20% v/v) 
as a plasticizer and 30 mg of cefadroxil were added in the solution, with continuous stirring 
until the drug completely dissolved in the solution. Subsequently, 15 mL film casting 
solution was casted onto a petri-dish (100 x 10 mm) precoated with polyurethane and was 
kept in an oven at 37 °C for complete drying. Prepared film was washed with 50% v/v 
ethanol to remove surface bound traces of glacial acetic acid. Dried film was carefully 
peeled out and stored in desiccator containing saturated sodium bromide.  
Preparation of Cefadroxil Loaded Chitosan-Furfural Films (1:1 and 1: 0.5) (F2 & F3) 
Chitosan-furfural film was prepared by following the reported method, using different mole 
ratio of chitosan to furfural [25]. Accordingly, 1 g chitosan was dissolved in 6.4 mL acetic 
acid solution (1% v/v) by vigorous agitation for 30 minutes. The solution containing vessel 
was immersed in boiling water bath for 10 minutes, cooled to room temperature and 
solution was filtered through glass-wool to remove undissolved particles of chitosan. The   Development and Evaluation of Cefadroxil Drug Loaded Biopolymeric Films Based on …   911 
Sci Pharm. 2010; 78: 909–925. 
filtrate was treated with 6.4 mL furfural solution (1 mL furfural dissolved in 5 mL isopropyl 
alcohol). The mixture was stirred continuously for 8 hours at 37  °C. After that 3.2 mL 
glycerol (20% v/v) as a plasticizer and 30 mg of cefadroxil were added in the resultant 
solution by continuous stirring until formation of clear solution. Subsequently, 15 mL 
solution was casted onto a petri dish, precoated with polyurethane and kept it in oven at 
37 °C for complete drying. Prepared film was washed with 50% v/v ethanol to remove 
surface bound traces of acid. Dried film was carefully peeled out and stored in desiccator 
containing saturated sodium bromide until further tests.  
Preparation of Chitosan-Furfural (1:1) Film in Presence of Perchloric Acid (F4) 
Cross-linked chitosan–furfural film was prepared by the method reported in the literature 
[26]. Accordingly, 1 g chitosan was dissolved in 6.4 mL acetic acid (1% v/v) solution by 
vigorous agitation for 30 minutes. The solution containing vessel was immersed in boiling 
water bath for 10 minutes, cooled down to room temperature, and solution was filtered 
through glass-wool to remove undissolved particles of chitosan. To this solution, 0.05 mL 
perchloric acid was added drop by drop at 0 °C temperature by keeping mixture containing 
vessel in ice bath. Then, 6.4 mL furfural was added (1 mL furfural was dissolved in 5 mL 
isopropyl alcohol) under continuous stirring for 45 minutes. After that 3.2 mL glycerol (20% 
v/v) as a plasticizer and 30 mg cefadroxil were added in the resultant solution by 
continuous stirring until the formation of clear solution. Subsequently, 15 mL solution was 
casted onto a petri-dish precoated with polyurethane and content was dried in a vacuum 
oven. Produced film was washed with 50% v/v ethanol to remove surface bound traces of 
acid. Dried film was carefully peeled out and stored in desiccator containing saturated 
sodium bromide until further tests. The compositional data for all the film formulations are 
presented in Table 1. 
Tab. 1.  Composition of Various Cefadroxil Drug Loaded Chitosan Films
a 
Formulation  
Code 
Chitosan
(% w/v) 
Furfural
(%v/v) 
Glycerol  
(%) 
Drug
(mg) 
F1 – Chitosan in acetic acid  1.0  –  20  30 
F2 – Chitosan-furfural (1:1) film  
in presence of acetic acid  1.0 1.0 20  30 
F3 – Chitosan-furfural (1:0.5) film  
in presence of acetic acid  1.0 0.5 20  30 
F4 – Chitosan-furfural (1:1) film  
in presence of perchloric acid  1.0 1.0 20  30 
a 15 mL film casting solution was used for the preparation of film. 
 
Physical and Mechanical Characterization of Films 
The conventional and modified chitosan films were evaluated for their physical properties 
like thickness, percent elongation, tensile strength, folding endurance, water content, 
surface pH and SEM. The formation of schiff base during the reaction was confirmed by IR 
spectral analysis. 
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Thickness of the Films 
A micrometer was used to measure the thickness of the film with least count of 0.001 mm 
prior to all the tests. Mean of five measurements across each film specimen was 
determined. To determine weight uniformity of the each film, five specimens of size 2.0 cm 
of all films were weighed on electronic balance and mean weight was calculated.  
Tensile Strength and % Elongation  
Tensile strength was evaluated using an Instron Universal Testing instrument (Model 
4206, Instron Ltd., Japan) with a 2 kg load cell. Film of the required dimension without any 
air bubbles or physical imperfections was held between two clamps positioned at a 
distance of 3 cm. During the measurement, the top clamp was pulled at a rate of 100 
mm/minutes and the force and elongation were measured upon breaking the films. The 
results from film sample that broke down between the clamps were used. Measurements 
were run in triplicate for each film. Tensile strength and percent elongation were calculated 
by applying the following equations: 
sample the of area tional cross Initial
N break at Force
strength Tensile
sec
) (
=  
100 % × =
length Original
length in Increase
Elongation  
Folding Endurance Test  
The folding endurance of the film was determined by repeatedly folding one film at the 
same place till it broke down or folded up to, which is considered satisfactory to reveal 
good film properties [27]. The number of times the film could be folded at the same place 
without breaking gave the value of the folding endurance. 
Equilibrium Water Content and Swelling Ratio of the Films 
All the prepared films were tested by placing each film in 30 mL distilled water and 
incubated at 37 °C. At an appropriate time interval, the films were taken out and excess 
water was removed from the film carefully using filter paper and films were weighed 
immediately. The swelling of film was expressed as a swelling ratio (SR) using following 
equation:  
0
0 t
W
W -   W
= SR  
Where : W0 is the weight of dry sample (g) and Wt is the weight of the sample (g) at time ‘t’ 
after incubation for 30 minutes. 
Surface pH 
To measure the surface pH, prepared films were left to swell for 2 hrs. in double distilled 
water with stirring. The surface pH was measured by means of a pH paper (strip) placed 
on the surface of the swollen film. The mean of two readings was duly recorded.    Development and Evaluation of Cefadroxil Drug Loaded Biopolymeric Films Based on …   913 
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Infrared Spectroscopy 
Infrared spectra of all the films were carried out using KBr disc technique on Perkin-Elmer 
Spectrum GX FT-IR model at SICART, Vallabh Vidyanagar. 
Differential Scanning Calorimetry  
DSC curves for all the prepared films were obtained using the Mettler TA 3000 DSC 
apparatus. The film was heated from 50 °C to 450 °C at a heating rate of 10 °C/minutes, at 
SICART, Vallabh Vidyanagar. 
Scanning Electron Microscope (SEM) Study 
The morphology and surface topography of the film was examined by SEM using model 
JSM-840 A, SEM–Jeol, Japan, at E.R.D.A., Makarpura, GIDC, Baroda. Spherical samples 
(5 mm to 2 mm) were mounted on the SEM sample stab using a double-sided sticking 
tape. The samples were coated with platinum (200 A°) under reduced pressure (0.001 torr) 
for 2 minutes using an ion sputtering device (model JFC-1100 E, Jeol, Japan). The 
platinum-coated samples were observed under the SEM and photomicrographs of suitable 
magnifications were obtained. 
Determination of Drug Content 
The concentration of the cefadroxil in all the films was determined by spectrophotometry 
[28]. Film was weighed accurately and quantitatively transferred into a 100 mL volumetric 
flask, which was diluted up to the mark with distilled water. This mixture was stirred for 24 
hrs. to allow the total release of the drug from the film. After filtration the filtrate was 
assayed using ultraviolet spectrophotometer at the wavelength of maximum absorbance. 
The assay was performed in triplicate. The percentage of the drug content of the film was 
calculated by the following equation: 
100 ) / (% × =
film of mass
drug of mass
w w Content Drug  
In Vitro Drug Release Study 
Dissolution Studies 
Tab. 2.  Operating Parameters for dissolution test apparatus type II 
Operating parameter  Value 
Rotation speed  100 rpm 
Dissolution medium  Water 
pH of dissolution medium  7 pH 
Volume of dissolution medium  900 ml 
Temperature  37 ± 0.5 °C 
Pre-determined time intervals 
for sampling 
60, 120, 180, 240, 
300, 360, 420 min. 
Sample volume  5 ml 
Wavelength 263  nm 
Filter membranes  0.2 μm 914  R. B. Dixit et al.:    
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Each type of film was introduced into each of three dissolution vessels (i.e. in triplicate) 
and the dissolution was determined according to the USP (1995:2330) apparatus type II 
(paddle). After withdrawal of a 5 ml sample, it was immediately replaced with 5 ml of pre-
heated dissolution medium. The samples were filtered through a 0.20 µm membrane and 
then analyzed with a UV spectrophotometer at the wavelength of maximum absorbance 
(263 nm). The operating conditions for the dissolution tests are summarized in Table 2. 
Antibacterial Activity 
The bacteriostatic effect of the films containing cefadroxil was determined by agar-plate 
diffusion assay [29]. A cotton swab charged with Staphylococcus aureus (ATCC 25923), 
klebsiella pneumoniae (ATCC 13883), Escherichia coli (ATCC 25922)  and Proteus 
vulgaris (ATCC 13315) suspension (106 CFU/mL) were inoculated on plates and bacteria 
was spread evenly over the surface of the Luria agar media. Then, films (1 cm x 1 cm) 
were placed on inoculated agar-plates. These plates were incubated at 37 °C for 24 hrs. 
and the zone of inhibition were measured and recorded. The films were removed 
individually from the plates, dabbed on a sterile swab to remove surface moisture, and 
immediately transferred to another fresh plate inoculated with the same bacteria. This 
procedure was repeated until no zone of inhibition was seen (> 10 mm).  
Results and Discussion 
Physical and Mechanical Characterization of Films 
Chitosan containing free amino group was reacted with furfural under two different reaction 
conditions. In the presence of acetic acid as a catalyst, amino group of chitosan was 
reacted with aldehyde group of furfural to produce light yellow coloured biopolymeric Schiff 
base [19] films (F2 and F3). While, in the presence of perchloric acid as a catalyst, furfural 
ring might have been opened up to form aliphatic Schiff base [30, 31] with two different 
chitosan repeating units to produce cross-linked dark yellow coloured biopolymeric film 
(F4). Composition of various cefadroxil drug loaded chitosan films are shown in Table 1 
and their physical and mechanical properties are included in Table 3. The mean thickness 
of the film formulations was measured and found within the range of 0.08 ± 0.02 to 0.13 ± 
0.02 mm. The weight of different film formulation was measured and found within the 
range of 0.99 ± 0.05 gm to 1.25 ± 0.09 gm. There was no significant variation in the weight 
of the films. The result shows that the method of preparation of films was consistent. 
Folding endurance test results indicated that none of the film breaks until it is folded 170 
times, which showed that the films would not broke down and that they maintain their 
integrity with general skin folding when applied. There was an influence of the film 
composition on the swelling of the chitosan films. However, an increase in weight was not 
observed even after keeping films in water up to 24 hrs. Whereas, changes in the diameter 
of the F1 film to greater expansion and swelling was observed, this behavior is associated 
with the solubility of chitosan-acetate in water. On the other hand F2 and F3 films 
formulations showed lower swelling ratio in comparison of F4 film due to cross-linking of 
chitosan with furfural. Tensile strength of all the film formulations was within the range of 
1.12 to 1.44 kg/mm
2 and % elongation was within the range of 29.0% to 33.0%. The 
results of tensile strength and % elongation were found to be satisfactory for all the 
formulations. The F4 film formulation showed highest tensile strength and the F1 film 
formulation showed lowest tensile strength. On the other hand elongation was greatest for 
F1 film compared to all other films.   Development and Evaluation of Cefadroxil Drug Loaded Biopolymeric Films Based on …   915 
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Tab. 3.  Evaluation of Chitosan Films 
Film Formulation Code  Sr. 
no. Parameters 
F1 F 2 F 3 F 4 
1  Thickness (cm)    0.08 ± 0.02   0.11 ± 0.02   0.12 ± 0.02    0.13 ± 0.02
2  Mass of 2.0 cm Diameter 
Films (gm)    0.99 ± 0.05   1.08 ± 0.01   1.23 ± 0.02    1.25 ± 0.09
3  Tensile Strength (kg/mm
2)    1.12 ± 0.01   1.21 ± 0.01   1.19 ± 0.01    1.44 ± 0.01
4 (%)  Elongation  32.89 ± 0.85 31.02 ± 1.77 29.04 ± 1.74  28.96 ± 1.66
5  Surface  pH  5.70 5.90 5.93 5.97 
6  Swelling ratio of films 
(gm/gm)    1.11 ± 0.08   0.86 ± 0.10   0.75 ± 0.10    0.91 ± 0.07
7  Cefadroxil Content 
(mg/film)  28.19 ± 0.22 27.87 ± 0.62 27.82 ± 0.57  27.91 ± 0.51
(Presented values: mean ± S.D., n=3) 
 
 
Fig. 1.  FT-IR spectra of Chitosan and F1 film 
Infrared Spectroscopy 
Investigation of IR spectral data of chitosan films showed a broad band around 3490 cm
−1 
due to presence of –OH and –NH2 groups. Most significant part of the spectrum was 
bands appeared at 1668 and 1320 cm
−1 due to amide group. There were characteristic 
bands at 1462, 1415, 1378, 1178 and 810 cm
−1, in addition to the usual broad band at 
2880 cm
−1, which are in good agreement with the reported IR spectrum of chitosan   
[32–34]. The reaction of chitosan with furfural forms the biopolymeric Schiff base. The IR 
spectra of Schiff base biopolymeric films showed a strong absorption band at 3360 cm
−1 
for the –OH group. The band at 1410 and 1633 cm
−1 may be attributed to the C=N vibra-
tion characteristics of imine group [13, 14]. On the other hand, there was no evidence for 
the presence of aromatic aldehyde group of furfural near 1670 cm
−1 in the IR spectrum of 916  R. B. Dixit et al.:    
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Schiff base polymer. The IR spectrum confirms the imine formation represented by the 
absorption band in the region of 1540 -1590 cm
−1, which was not observed in the original 
chitosan spectrum. Moreover, the band appeared at 1096 and 1251 to 1320 cm
−1 in the 
spectrum of cross-linked film shows the presence of 2° alcohol [30, 31]. It might be due to 
opening of furfural ring during formation of Schiff base, which confirms the cross-linking of 
furfural with the two units of chitosan. The IR spectra of all four films are shown in Figures 
1 and 2.  
 
Fig. 2.  FT-IR spectra of F2 to F4 films 
Differential Scanning Calorimetry  
DSC data of all the films are included in Table 4 and DSC spectra are shown in Figure 3. 
Scrutinization of DSC spectra shows that F1 film of chitosan exhibits two endothermic 
peaks at 90 and 289 °C and two exothermic peaks at 310 and 456 °C, which are very 
close to the reported data of chitosan [35]. Similarly, DSC data of F2, F3 and F4 films were 
also in close agreement with the reported data of chitosan, but shows absence of fourth 
stage exothermic peak. This confirms the structural modification of chitosan upon addition 
of furfural, which may result in to a linear or cross-linked biopolymeric films depending 
upon the reaction condition. 
Tab. 4.  DSC Thermograms of Biopolymeric Films  
First Stage  Second Stage  Third Stage  Fourth Stage 
Film  Peak Temp. (°C)  
(Endothermic heat flow) 
Peak Temp. (°C) 
(Exothermic heat flow) 
F1 90  289  310  456 
F2 98  280  400  – 
F3 98  282  412  – 
F4 102  285  439  –   Development and Evaluation of Cefadroxil Drug Loaded Biopolymeric Films Based on …   917 
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Fig. 3.  Differential Scanning Calorimetry Spectra of F1 to F4 films 
Scanning Electron Microscope Study 
Scanning electron microscopic (SEM) study of different film formulations was performed 
and the SEM results of films F1 to F4 are shown in Figures 4 to 7 respectively. Observation 
of SEM of film F1 showed voids on the surface, while in case of F2, F3 and F4 films such 
kind of voids were not observed. Absence of voids in the F2, F2 and F4 films might be due 
to the cross-linking of chitosan with furfural. 
 
Fig. 4.   Scanning electron microscope photograph of F1 film formulation. 918  R. B. Dixit et al.:    
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Fig. 5.   Scanning electron microscope photograph of F2 film formulation. 
 
Fig. 6.  Scanning electron microscope photograph of F3 film formulation.   Development and Evaluation of Cefadroxil Drug Loaded Biopolymeric Films Based on …   919 
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Fig. 7.   Scanning electron microscope photograph of F4 film formulation. 
Drug Content 
The drug content uniformity among the different films was observed in the range of 27.00 
to 29.00 mg/film. The results indicate that the process employed to prepare films in the 
present work is capable of producing films with uniform drug content with minimum 
variation. Thus, the results showed that all the films having drug content uniformity within 
the acceptable range. 
In vitro Permeation Studies using Dialysis Membrane 
The diffusion cell was fabricated with the help of small funnel. The donor compartment was 
funnel of dish size 3.5 cm diameter. The film formulations F1, F2, F3 and F4 of 1.5 cm
2 
surface areas were placed on dialysis membrane individually with aluminum foil as 
membrane, which was then tied to the diffusion cell. This diffusion cell was immersed in 
beaker containing 50 ml of phosphate buffer (pH 7.4) [36] and methanol (50% v/v) as 
diffusion media receptor compartment. The solution was stirred using magnetic stirrer at 
the speed of 100 rpm by maintaining the temperature of the whole assembly at 37 °C. The 
amount of the drug release was determined by withdrawing 2 ml of sample at specific time 
interval up to 12 hrs. The volume withdrawn was replaced with equal volume of fresh and 
pre-warmed phosphate buffer media containing methanol. The absorbance of the 
withdrawn sample was measured at 240 nm to estimate cefadroxil [37].  
In Vitro Drug Release Study 
The film formulations F1, F2, F3 and F4 loaded with cefadroxil were subjected to in vitro 
drug release study using dissolution test apparatus type-II. The results of percent drug 
release of films at different time point is shown in Figure 8, while percent cumulative drug 920  R. B. Dixit et al.:    
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release is shown in a Figure 9. Scrutinization of Figures 8 and 9 showed that in F1 film, a 
rapid drug release was observed, while in F2 and F3 films drug released at moderate rate. 
This might be due to the formation of schiff base between chitosan and furfural. F4 film 
showed slow drug release which might be due to entrapment of cefadroxil drug molecules 
between cross-linked chitosan polymeric chains. 
The drug release data for different batches was analyzed using PCP DISSO software [38] 
version 3.0, developed by Poona College of Pharmacy, Pune, India. Table 5 lists various 
dissolution kinetics parameters computed for all the four films (F1 to F4). In the present 
study, all four formulations followed zero order release pattern (Figure 8). 
Tab. 5.  Dissolution Kinetics Parameters for the films F1 to F4 
Film Formulation  N  K  r
2 
F1 0.9844  14.24  0.9839 
F2 0.7954  15.55  0.9858 
F3 0.9494  55.40  0.9895 
F4 0.8900  30.50  0.9019 
 
 
 
0
20
40
60
80
100
012345678
Time (h)
P
e
r
c
e
n
t
 
D
r
u
g
 
R
e
l
e
a
s
e
d
F1 F2 F3 F4
 
Fig. 8.  In vitro drug release profile of percent drug release Vs time for different film 
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Fig. 9.   In vitro drug release profile of percent cumulative drug release Vs time for 
different film formulations. [Graph shows S.D. of triplicate experiments] 
 
Tab. 6.   Zone of Inhibition Value (cm) of Different Film Formulations against Various 
Bacterial Species 
S. aureus*  K. pneumoniae*  Days 
F1 F 2 F 3 F 4 F G F1 F 2 F 3 F 4 F G 
1  1.0 0.3 0.5 0.7 0.4 0.3 1.1 0.6 0.8 0.9 0.4 0.5 
2  1.1 0.9 1.1 1.3 0.7 0.6 1.5 0.9 1.1 1.2 0.6 0.6 
3  1.5 1.7 1.9 1.7 1.0 0.9 1.7 1.1 1.4 1.5 0.9 0.8 
4  1.5 1.9 2.1 2.0 1.1 1.1 1.9 1.3 1.7 1.7 1.2 1.3 
5  1.5 2.2 2.3 2.2 1.2 1.2 1.9 1.9 1.9 2.0 1.3 1.3 
6  1.5 2.7 2.3 2.2 1.4 1.3 1.9 2.1 2.3 2.1 1.3 1.3 
E. coli*  P. vulgaris*  Days 
F1 F 2 F 3 F 4 F G F1 F 2 F 3 F 4 F G 
1  1.1 0.6 0.8 0.9 0.7 0.6 0.8 0.5 0.6 0.9 0.2 0.3 
2  1.5 0.9 1.1 1.2 0.9 0.8 0.9 0.9 0.7 1.0 0.3 0.3 
3  1.7 1.1 1.4 1.5 1.0 1.0 1.0 0.9 0.9 1.3 0.4 0.4 
4  1.9 1.3 1.7 1.7 1.2 1.1 1.0 1.1 0.9 1.4 0.5 0.4 
5  1.9 1.9 1.9 2.0 1.3 1.4 1.1 1.1 1.9 1.4 0.6 0.5 
6  1.9 2.1 2.3 2.1 1.4 1.5 1.1 1.1 1.4 1.5 0.6 0.5 
* Cefadroxil as standard and its zone of inhibition was 2.3 to 2.8 cm in 3 to 4 d;  
F…Furfural; G…Glycerol 922  R. B. Dixit et al.:    
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Antibacterial Activity 
The antibacterial activity of different film formulations were carried out against S. aureus, 
K. pneumoniae (Gram positive)  and  E. coli,  P. vulgaris (Gram negative) bacteria of 
different films. To measure the zone of inhibition of different film formulations F1, F2, F3 and 
F4, experiments were performed in triplicates and the average value of results is 
summarized in Table 6. Results of antibacterial activity showed that S. aureus, K. 
pneumoniae and E. coli have good to moderate activity as compare to P. vulgaris bacteria. 
Moreover, prolonged drug release was observed for the films F2, F3 and F4 as compare to 
F1 film. 
Conclusion 
Novel biopolymeric schiff base films were developed for the release study of cefadroxil 
drug, which can be used for external application in the form of dermal patches. Modified 
chitosan films have better physical properties and mechanical strength as compare to 
chitosan films. Drug release study of the plain chitosan film and modified chitosan films 
were compared and it was observed that modified chitosan films shows better release 
profile than plain chitosan films. Drug loaded modified chitosan films showed significant 
antibacterial activity as compare to chitosan drug loaded film.  
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